Neuroprotective effects of PPARα in retinopathy of type 1 diabetes-Reference-Cited by-同舟云学术

Neuroprotective effects of PPARα in retinopathy of type 1 diabetes

Published:2019-02-04 Issue:2 Volume:14 Page:e0208399
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pearsall Elizabeth A.,Cheng Rui,Matsuzaki Satoshi,Zhou Kelu,Ding Lexi,Ahn Bumsoo,Kinter Michael,Humphries Kenneth M.,Quiambao Alexander B.,Farjo Rafal A.,Ma Jian-xing^ORCID

Funder

National Eye Institute

Juvenile Diabetes Research Foundation International

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Diabetic retinopathy;DA Antonetti;N Engl J Med,2012

2. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications;MS Stem;Curr Med Chem,2013

3. Neuroprotection for diabetic retinopathy;H Imai;Dev Ophthalmol,2009

4. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial;AC Keech;Lancet,2007

5. Effects of medical therapies on retinopathy progression in type 2 diabetes;AS Group;N Engl J Med,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease;Ophthalmology Science;2024-09

2. Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial;BMJ Open;2024-02

3. Oxidative stress in the eye and its role in the pathophysiology of ocular diseases;Redox Biology;2023-12

4. Retinal Cell Damage in Diabetic Retinopathy;Cells;2023-05-08

5. Therapeutic roles of PPARα activation in ocular ischemic diseases;HISTOL HISTOPATHOL;2023